The American Journal of Medicine
Volume 122, Issue 3 , Pages 205-206 , March 2009

Obesity Surgery and Diabetes: Does a Chance to Cut Mean a Chance to Cure?

  • Stuart R. Chipkin, MD

      Affiliations

    • School of Public Health and Health Sciences, University of Massachusetts, Amherst
  • ,
  • Robert J. Goldberg, PhD

      Affiliations

    • University of Massachusetts Medical School, Division of Cardiovascular Medicine, Worcester

References 

  1. The Diabetes Control and Complications Trial Research Group. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  2. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–256
  3. Pories WJ, MacDonald KG, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up 13. Am J Clin Nutr. 1992;55:582S–585S
  4. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparascopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467–485
  5. Rewers M, Zaccaro D, D'Agostino R, et al. Insulin Resistance Atherosclerosis Study Investigators Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27:781–787
  6. Rosen CJ. The Rosiglitazone Story-Lessons from an FDA advisory committee meeting. N Engl J Med. 2007;357:844–846

 Funding: There is no relevant funding source for this work.

 Conflict of Interest: Neither author has any conflict of interest regarding this work.

 Authorship: Both authors participated in the preparation of this manuscript.

PII: S0002-9343(08)01210-2

doi: 10.1016/j.amjmed.2008.11.016

The American Journal of Medicine
Volume 122, Issue 3 , Pages 205-206 , March 2009